Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Czechia / NCT07457814
Starting soon Observational

Postoperative Pain and Analgesic Use After Total Knee Arthroplasty

NCT07457814 · tracked via the Priya Life Science Czechia tracker
Phase
Observational
Started
2026-03-01
Last updated
2026-03-09

Condition(s) studied

Postoperative Pain After Total Knee ArthroplastyPostoperative PainAnalgesic Consumption

Study summary

This prospective observational study evaluates postoperative pain intensity and analgesic consumption in patients undergoing total knee arthroplasty (TKA) under different anesthesia techniques. Patients receive either general anesthesia with peripheral nerve block, spinal anesthesia with peripheral nerve block, spinal anesthesia alone, or general anesthesia with an epidural catheter. Pain scores (NRS), analgesic use, adverse effects, patient satisfaction, and the need for therapeutic interventions are assessed during the first 48 hours after surgery. The study aims to identify differences in postoperative pain control and factors associated with hypotension and other complications.

Eligibility

Sex
ALL
Min age
18 Years
Max age
100 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Age 18-100 years * Primary total knee arthroplasty (TKA) * ASA physical status I-III * Glasgow Coma Scale (GCS) score of 15 * Ability to understand study procedures and provide informed consent * Ability to cooperate during pre-anesthetic evaluation * No severe sensory impairment (e.g., blindness, deafness) Exclusion Criteria: * Revision or reoperation of TKA * ASA score IV or higher * Refusal to participate or inability to provide informed consent * GCS ≤ 14 * Limited legal capacity * Active psychiatric disorder * Chronic use of strong opioid analgesics * Neurological disease affecting pain perception or cooperation * Cognitive impairment or language barrier preventing questionnaire completion * Use of anesthesia techniques other than GA + PNB or SA + PNB (e.g., epidural anesthesia, local infiltration without PNB)

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Tomas Bata regional hospital Zlín Czechia

More Tomas Bata Hospital, Czech Republic trials in Czechia

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07457814 on ClinicalTrials.gov ↗ ← All trials in Czechia